Silver Coating of Dialysis Catheters to Reduce Bacterial Colonization and Infection

Therapeutic Apheresis

Volumn 7, Issue 6, 2003, Pages 504-509

  Tobin, Eric J ^a   Bambauer, Rolf ^b  

^a Spire Biomedical Inc   (United States)

^b Institute for Blood Purification   (Germany)

Author keywords

Bacteria; Catheter; Hemodialysis; Infection; Ion beam assisted deposition; Silver coating

Indexed keywords

SILVER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BIOCOMPATIBILITY; CATHETER; CATHETER INFECTION; CONTROLLED STUDY; DIALYSIS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MATERIAL COATING; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; VASCULAR ACCESS;

ANIMALS; BACTERIAL INFECTIONS; CATHETERS, INDWELLING; CLINICAL TRIALS; COATED MATERIALS, BIOCOMPATIBLE; DISEASE MODELS, ANIMAL; EQUIPMENT CONTAMINATION; EQUIPMENT DESIGN; EQUIPMENT SAFETY; HUMANS; PERITONEAL DIALYSIS; RATS; RENAL DIALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SILVER;

EID: 0346363828     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2003.00097.x     Document Type: Review

References (26)

1. National Kidney Foundation. Kidney Disease Outcomes Quality Initiative: Vascular Access. Guideline 3. New York: National Kidney Foundation, 2000.
2. Department of Health and Human Services. Department of Health and Human Services, Health Care Financing Administration, Office of Clinical Standards and Quality 2000 Annual Report: End Stage Renal Disease Clinical Performance Measures Project. Baltimore, MD: Department of Health and Human Services, 2000.
3. Mandolfo S, Galli F, Costa S, Ravini P, Gaggia P, Imbasciati E. Factors influencing permanent catheter performance. J Vasc Access 2001;2:106-9.
4. Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int 2001:60:1-13.
5. Butterly DW, Schwab SJ. Dialysis access infections. Curr Opin Nephrol Hypertens 2000;9:631-5.
6. Little MA, O'Riordan A, Lucey B et al. A prospective study of complications associated with cuffed, tunneled hemodialysis catheters. Nephrol Dial Transplant 2001;16:2194-200.
7. Kairaitis LK, Gottlieb T. Outcome and complications of temporary haemodialysis catheters. Nephrol Dial Transplant 1999;14:1710-14.
8. Dahlberg PJ, Agger WA, Singer JR et al. Subclavian hemodialysis catheter infections, a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect Control Hosp Epidemiol 1995;16:506-11.
9. Babycos CR, Barrocas A, Webb WR. A prospective randomized trial comparing the silver-impregnated collagen cuff with the bedside tunneled subclavian catheter. J Parenter Enteral Nutr 1993;17:61-3.
10. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997;127:257-66.
11. Ciresi DL, Albrecht RM, Volkers PA, Scholten DJ. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 1996;62:641-6.
12. Darouiche RO, Raad II, Heard SO et al. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999;340:1-8.
13. Bambauer R, Mestres P, Schiel R, Klinkmann J, Sioshansi P. Surface-treated catheters with ion beam-based process evaluation in rats. Artif Organs 1997;21:1039-41.
14. Kathuria P, Moore HL, Mehrotra R, Prowant BF, Khanna R, Twardowski ZJ. Evaluation of healing and external tunnel histology of silver-coated peritoneal catheters in rats. Adv Perit Dial 1996;12:203-8.
15. Fung LC, Khoury AE, Vas SI, Smith C, Oreopoulos DG, Mittelman MW. Biocompatibility of silver-coated peritoneal dialysis catheter in a porcine model. Perit Dial Int 1996;16:398-405.
16. Bambauer R, Mestres P, Schiel R, Schneidewind-Muller JM, Bambauer S, Sioshansi P. Large bore catheters with surface treatments versus untreated catheters for blood access. J Vascular Access 2001;2:97-105.
17. Bambauer R, Mestres P, Schiel R et al. Surface treated large bore catheters with silver based coatins versus untreated catheters for extracorporeal detoxification methods. ASAIO J 1998;44:303-8.
18. Trerotola SO, Johnson MS, Shah H et al. Tunneled hemodialysis catheters: Use of a silver-coated catheter for prevention of infection - a randomized study. Radiology 1998;207:491-6.
19. Bambauer R, Mestres P, Schiel R, Sioshansi P. New surface-treatment technologies for catheters used for extracorporeal detoxification. Dial Transplant 1995;24:228-33.
20. Bambauer R, Mestres P, Pirrung KJ, Sioshansi P. Scanning electron microscopic investigation of catheters for blood access. Artif Organs 1994;18:272-5.
21. Bambauer R, Schiel R, Mestres P, Klinkmann J, Sioshansi P. Scanning electron microscopic investigation of catheters for blood access. Blood Purif 1996;14:249-56.
22. Bambauer R, Schiel R, Mestres P, Sioshansi P. Scanning electron microscopic investigations of surface treated large-bore catheters used for extracorporeal detoxification methods. Int J Artif Organs 1995;18:326-31.
23. Walder B, Pittet D, Tramer MR. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect Control Hosp Epidemiol 2002;23:748-56.
24. Lai KK, Fontecchio SA. Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. Am J Infect Control 2002;30:221-5.
25. Timsit JF, Farkas JC, Boyer JM et al. Central vein catheter-related thrombosis in intensive care patients: Incidence, risks factors, and relationship with catheter-related sepsis. Chest 1998;114:207-13.
26. McCarley P, Wingard RL, Shyr Y, Pettus W, Hakim RM, Ikizler TA. Vascular access blood flow monitoring reduces access morbidity and costs. Kidney Int 2001;60:1164-72.